期刊文献+

短期异常低温对重组乙型肝炎疫苗效力相关因素的影响

Effect of short-term abnormal low temperature storage on potency-related factors of recombinant hepatitis B vaccine
原文传递
导出
摘要 目的模拟重组乙型肝炎(简称乙肝)疫苗在冷藏存储过程中发生的异常低温情况,探讨短期异常低温储存对乙肝疫苗效力相关因素的影响。方法选取3个不同表达系统(酿酒酵母、汉逊酵母、CHO细胞)来源的乙肝疫苗,分别于0、-7、-20℃储存1或7 d,检测疫苗的吸附完全性、上清中铝离子含量、效价和体外相对效力,比较乙肝疫苗经短期异常低温储存后与2~8℃正常储存条件下的差异。结果经短期异常低温储存后,疫苗的吸附完全性、疫苗上清中铝离子含量未发生变化;3种乙肝疫苗的ED50在0.16~0.68μg之间波动;汉逊酵母乙肝疫苗体外相对效力的变化幅度不超过10%,酿酒酵母乙肝疫苗在-20℃冻存7 d后相对效力较2~8℃储存下降21.8%。结论短期异常低温储存后,乙肝疫苗仍能保持较好的吸附完全性,非胶体状态铝含量未发生变化,疫苗效价和体外相对效力在部分异常储存条件下出现下降,但仍符合质量标准要求。 Objective To investigate the effect of short-term abnormal low temperature storage on the potency-related factors of recombinant hepatitis B vaccine through simulating the abnormal temperature during storage and transportation.Methods A total of six batches of hepatitis B vaccine derived from three different expression systems(Saccharomyces cerevisiae,Hansenula polymorpha and CHO cells)were selected and stored at 0,-7 and-20 ℃ for 1 or 7 d separately.The difference in hepatitis B vaccines stored at low temperature and 2 ~ 8 ℃ were evaluated by determining the degree of adsorption,content of free aluminum in supernatant,in vivo potency and relative potency in vitro. Results After storage at low temperature for a short time,the degree of adsorption and content of free aluminum in supernatant of vaccine showed no significant change. The ED50 of vaccines derived from three expression systems were 0. 16 ~ 0. 68 μg. The change range of relative potency in vitro of vaccine derived from H. polymorpha was less than 10%,while that from S. cerevisiae decreased by 21. 8% after storage at-20 ℃ for 7 d as compared with that at 2 ~ 8 ℃. Conclusion Abnormal low temperature storage exerted less effect on the degree of adsorption and content of free aluminum of hepatitis B vaccines. Though declines of in vivo potency and relative potency in vitro were observed in certain abnormal conditions,the vaccines still met the standards for quality.
作者 方鑫 邱少辉 童海青 屈旭成 曹崴 饶洪冲 朱征宇 何鹏 胡忠玉 FANG Xin;QIU Shao-hui;TONG Hai-qing;QU Xu-cheng;CAO Wei;RAO Hong-chong;ZHU Zheng-yu;HE Peng;HU Zhong-yu(National Institutes for Food and Drug Control,Key Laborulory of the Ministry of Health for Research on Quality and Standardization of Biotech Producets,Beijing 102629,China)
出处 《中国生物制品学杂志》 CAS CSCD 2020年第4期361-365,共5页 Chinese Journal of Biologicals
基金 国家新药创制科技重大专项“创新生物技术药评价及标准化关键技术研究”(2018ZX09101001)。
关键词 乙型肝炎疫苗 低温 吸附完全性 效价 相对效力 Hepatitis B vaccine Low temperature Degree of adsorption Potency Relative potency
作者简介 通讯作者:胡忠玉.E-mail:huzy67@163.com;通讯作者:何鹏,E-mail:hepeng9553@163.com;方鑫,共享第一作者;邱少辉,共享第一作者。
  • 相关文献

参考文献2

二级参考文献18

  • 1许秋荣,胡宗汉.哺乳动物细胞酵母和痘苗病毒基因重组HBsAg生化纯度分析[J].中华实验和临床病毒学杂志,1993,7(1):30-34. 被引量:1
  • 2封多佳,温帼玲,程夷.概率单位平行线法在乙肝疫苗效力试验数据统计中的应用[J].中国生物制品学杂志,1994,7(3):141-143. 被引量:3
  • 3张弛 梁争论 李津 等.冻干重组(酵母)乙型肝炎疫苗参考品的三批小量试验研究.(等发表)[J].《微生物与免疫学进展》,.
  • 4Finney FJ.生物学统计分析法[M].伦敦:Char1s Griffn公司,1971..
  • 5中国生物制品规程,2000,:175-179.
  • 6WHO. Requirements for hepatitis B vaccines made by recombinant DNA technicals( Requirements for biological substances No. 45, amendment1997) .WHO Technical report series,No.889,1999.
  • 7Ferguson M, Heath A, Minor PD. Report of a collaborative study for assessing the potency of hepatitis B vaccine. Biologicals, 1990,18:345 -350.
  • 8Franks F. Long-term stabilization of biologicals. Biotechnology, 1994,12(3) :253 - 256.
  • 9Diminsky D, Schirmbeck R, Reimann J, et al. Comparison be- tween hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast eells(Hansenula polymorpha): composition, structure and immunogenicity [J]. Vaccine, 1997, 15 (6-7): 637-647.
  • 10Zhang Y, Ma JC, Qi SX, et al. Effectiveness of a Chinese hamster ovary cell derived hepatitis B vaccine in Chinese rural communi- ties [J]. Vaccine, 2011, 29 (22): 3905-3908.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部